Determining the Effective Sample Size of a Parametric Prior
From MaRDI portal
Publication:3506509
DOI10.1111/j.1541-0420.2007.00888.xzbMath1137.62014OpenAlexW2041098432WikidataQ41871357 ScholiaQ41871357MaRDI QIDQ3506509
Peter Mueller, Peter F. Thall, Satoshi Morita
Publication date: 13 June 2008
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3081791
Related Items
Robust meta‐analytic‐predictive priors in clinical trials with historical control information ⋮ The Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statistics ⋮ Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials ⋮ Web-based statistical tools for the analysis and design of clinical trials that incorporate historical controls ⋮ The Effective Sample Size ⋮ Graphical prior elicitation in univariate models ⋮ Effective sample size for a mixture prior ⋮ Iterated multisource exchangeability models for individualized inference with an application to mobile sensor data ⋮ Elastic priors to dynamically borrow information from historical data in clinical trials ⋮ Prior effective sample size in phase II clinical trials with mixed binary and continuous responses ⋮ DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses ⋮ Optimality of testing procedures for survival data in the nonproportional hazards setting ⋮ Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics ⋮ A Bayesian Singular Value Decomposition Procedure for Missing Data Imputation ⋮ The phoropter method: a stochastic graphical procedure for prior elicitation in univariate data models ⋮ Quantifying observed prior impact ⋮ On divergence measures leading to Jeffreys and other reference priors ⋮ Bayesian dynamic borrowing of historical information with applications to the analysis of large-scale assessments ⋮ Bayesian models and decision algorithms for complex early phase clinical trials ⋮ Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors ⋮ Control of type I error rates in Bayesian sequential designs ⋮ Bayesian sample size determination for binary regression with a misclassified covariate and no gold standard ⋮ Borrowing strength and borrowing index for Bayesian hierarchical models ⋮ A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes ⋮ Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials ⋮ Inference and Decision Making for 21st-Century Drug Development and Approval
Cites Work
- Unnamed Item
- Counting degrees of freedom in hierarchical and other richly-parameterised models
- Dose-Finding with Two Agents in Phase I Oncology Trials
- Bayesian Measures of Model Complexity and Fit
- Bayesian Approaches to Randomized Trials
- Parameterization and Bayesian Modeling
- Statistical Methods for Eliciting Probability Distributions
